Single Lyophilization Process for Somatostatin Sustained Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current processes for preparing sustained release pharmaceutical compositions of somatostatin analogues are complex and often fail to produce consistent products, particularly in maintaining a narrow pH range, which affects the solubility and injectability of the peptides.

Innovation Solution

A simpler process involving a single lyophilization step is employed, combining a gellable somatostatin analogue salt with an aqueous acid solution, followed by lyophilization and hydration, to achieve a final pH range of 5 to 7, ensuring consistent pH and improved injectability and release profiles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If multiple lyophilization steps are used to prepare sustained release compositions, then the pH consistency and product uniformity improve, but the process complexity and manufacturing time increase

Engineering Contradiction:
ImprovepH consistencyVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent extracts and removes one of the two lyophilization steps from the conventional process, retaining only a single lyophilization step that is sufficient to achieve the desired pH consistency and product uniformity. This simplification reduces process complexity while maintaining manufacturing precision.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent modifies process parameters (such as lyophilization conditions, excipient ratios, and pH adjustment parameters) to achieve consistent pH (5-7) and uniform product formation with a single lyophilization step, eliminating the need for multiple steps while maintaining manufacturing precision.

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If a single lyophilization step is used to simplify the process, then the manufacturing time and process complexity reduce, but the pH consistency and product uniformity may deteriorate

Engineering Contradiction:
Improveprocess complexityVSAvoidpH consistency
Core Design Contradiction:
Device complexityVSManufacturing precision

Solution Approach 1:

The patent optimizes process parameters including excipient concentrations, lyophilization conditions, and pH adjustment levels to achieve consistent pH (5-7) and uniform product formation with a single lyophilization step, thereby maintaining manufacturing precision while reducing process complexity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces specific excipients and pH adjustment agents as intermediaries that facilitate uniform product formation and pH control during the single lyophilization step, ensuring that pH consistency is maintained even with the simplified process.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If the pH range is widened to improve injectability, then the ease of administration improves, but the solubility and sustained release characteristics deteriorate

Engineering Contradiction:
ImproveinjectabilityVSAvoidsolubility
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent optimizes the pH parameter to a specific range (5-7) that balances injectability and solubility. This parameter optimization ensures that the composition is both easy to administer and maintains proper solubility characteristics for sustained release.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent ensures uniform pH distribution throughout the composition (local quality) to maintain consistent solubility and injectability characteristics, preventing localized variations that could compromise either parameter.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process results in pharmaceutical compositions with consistent pH, improved injectability, and extended release of somatostatin analogues over several weeks, facilitating easier administration and controlled drug release.

Implementation Method 1

combining a gellable somatostatin analogue salt and an aqueous acid solution

Methodology Applied
Scientific EffectGelation: Gel

Implementation Method 2

lyophilizing the resulting mixture only once

Methodology Applied
Scientific EffectLyophilization: Freeze Drying

Data Source

PatentUS10206968B2Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
Publication Date: 2019.02.19 IPSEN PHARMA SAS
  • US10206968B2 patent drawing
  • US10206968B2 patent drawing
  • US10206968B2 patent drawing

AI summary

A process for the preparation of injectable pharmaceutical compositions for the sustained release of somatostatin analogs and compositions prepared according to the process. The process may comprise lyophilizing a mixture of lanreotide acetate and acetic acid to form a lyophilizate and hydrating the lyophilizate, wherein the lyophilization is performed only once.